Table 3.
Detection of Synergy in Blocking Cell Entry of Ebola Virus–Like Particles
Drug 1 | Top Concentration, μM | Drug 2 | Top Concentration, μM | Log Synergy Volumea | Experiments, No.b |
---|---|---|---|---|---|
Apilimod | 0.1 | Bepridil | 10 | 11.98 | 2 |
Sertraline | 10 | Toremifene | 5 | 6.57 | 2 |
Apilimod | 0.1 | Toremifene | 5 | 6.00 | 2 |
Bepridil | 10 | Toremifene | 5 | 3.58 | 2 |
Clomiphene | 5 | Clomiphenec | 5 | 0.63 | 3 |
Four drug combinations were tested for ability to block Ebola virus–like particle entry, and synergistic effects were determined using MacSynergy software, as described in the Supplementary Methods.
aMacSynergy scores are given at the 99.9% confidence interval. Log synergy volume is averaged over the number of experiments.
bTwo or 3 plates were analyzed in each experiment.
cThe self-cross pair clomiphene/clomiphene was used as an expected negative control.